High dose vitamin C therapy
Pro Research Analysisby 
Searched over 200M research papers
High-Dose Vitamin C Therapy: Efficacy and Safety in Critical Illness and COVID-19
High-Dose Vitamin C in Severe Burn and Critical Illness Patients
Research shows that high-dose vitamin C therapy, particularly when administered early and at a threshold above 10 grams within the first two days of admission, is associated with reduced in-hospital mortality in patients with severe burns. However, increasing the dose above 24 grams did not show additional mortality benefits, suggesting that the definition and dosing of "high-dose" vitamin C are important factors in its effectiveness .
Safety Profile and Adverse Events of High-Dose Vitamin C
A comprehensive review of studies in adults found no consistent evidence that intravenous high-dose vitamin C is more harmful than placebo in double-blind randomized controlled trials. While most studies reported no significant increase in adverse events, some rare but notable risks were identified, including oxalate nephropathy, hypernatremia, hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, glucometer errors, and kidney stones. These findings highlight the need for specific monitoring in at-risk populations . In pediatric patients, high-dose vitamin C was not associated with any reported harmful effects or clinical efficacy, indicating a need for further research in this group .
High-Dose Vitamin C in COVID-19 Patients
Several studies have explored the use of high-dose vitamin C in COVID-19 patients. Evidence suggests that high-dose intravenous vitamin C may reduce mortality and improve oxygen support status in patients with COVID-19, without significant adverse events . Another clinical study confirmed the safety of high-dose vitamin C in non-ICU hospitalized COVID-19 patients, showing no adverse reactions or negative impact on renal function. While the therapy did not significantly reduce mortality or ICU admissions, it was associated with shorter hospital stays .
High-Dose Vitamin C in Cancer Therapy
Preclinical studies indicate that high-dose intravenous vitamin C can reach plasma concentrations that are cytotoxic to cancer cells and may inhibit tumor growth. However, these promising effects have not been consistently observed in human studies with advanced-stage cancer patients. There is no strong evidence supporting the use of high-dose vitamin C to enhance chemotherapy effectiveness or reduce its toxicity. Nonetheless, some reports suggest it may improve quality of life and reduce symptoms such as fatigue and bone pain in palliative care settings, though placebo effects cannot be ruled out 47. Recent research also suggests that combining high-dose vitamin C with other therapies, such as immunotherapies or targeted drugs, may enhance its anticancer effects, but more clinical evidence is needed .
High-Dose Vitamin C and Inflammation in Cancer Patients
In breast cancer patients undergoing radiotherapy, high-dose vitamin C was associated with a significant reduction in the neutrophil-lymphocyte ratio (NLR), a marker of systemic inflammation linked to higher mortality in cancer patients. This suggests a potential anti-inflammatory benefit of high-dose vitamin C during cancer treatment .
High-Dose Vitamin C and Renal Protection
Animal studies indicate that high-dose vitamin C administered during reperfusion can reduce renal dysfunction and tissue damage following ischemia-reperfusion injury, primarily by decreasing oxidative stress and inflammation. The optimal dose appears to be 200 mg/kg, with higher doses offering no additional benefit .
Conclusion
High-dose vitamin C therapy shows potential benefits in reducing mortality in severe burn and COVID-19 patients, with a generally favorable safety profile when monitored appropriately. Its role in cancer therapy remains uncertain, with some evidence for symptom relief but not for improved survival or chemotherapy enhancement. The therapy may also help reduce inflammation in cancer patients and protect against renal injury in specific settings. Further research is needed to clarify optimal dosing, patient selection, and combination strategies for maximizing the benefits of high-dose vitamin C therapy.
Sources and full results
Most relevant research papers on this topic